Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom pavlish who wrote (724)	5/14/1999 12:06:00 PM
From: StockMiser	Read Replies (2) of 2344

Tom - that is the most ill-informed piece of nonsense I've ever read on this message board. BIOM has HUGE amounts of cash - more than enough to complete the Theratope trial - and even beyond that. Several milestone payments are also scheduled, increasing cash even further. If you want to worry about burns, looks at some of the companies in much earlier phase trials with a lot less cash....but certainly NOT Biomira. With the cash on hand, and corporate alliances (BIOM got 500K from Biovector, 1 million from Chiron, btw, and about 30 million more to come), one of Biomira's biggest advantages is that they are in final phase trials and are in absolutely NO need of additional funds. ROFL! There are no "red flags". All biotech investors know how this works. Biotechs in research phase spend money. Go buy AOL or something and leave biotech investing to those that understand the risk/reward. ROFL! SM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next